These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6287837)

  • 1. Age as a criterion for eligibility in a lung cancer clinical trial.
    Lee JY; Marks JE; Siompson JR
    Am J Clin Oncol; 1982 Aug; 5(4):449-52. PubMed ID: 6287837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiotherapy combined with chemotherapy for carcinoma of the lung (author's transl)].
    Morita K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1977 Sep; 37(9):864-70. PubMed ID: 199887
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the combined procedure of Hp-D (hematoporphyrin derivative) phototherapy and radiation therapy in advanced lung cancer].
    Ono R; Ikeda S
    Nihon Gan Chiryo Gakkai Shi; 1986 Oct; 21(9):2189-95. PubMed ID: 3029251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy for lung cancer in view of internal medicine].
    Shiraishi J; Saijo N
    Kokyu To Junkan; 1993 Sep; 41(9):815-24. PubMed ID: 8210738
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience.
    Madej PJ; Bitran JD; Golomb HM; Hoffman PG; DeMeester T; Desser RK; Kaul R; Raghavan V; Newman SB; Skosey C
    Cancer; 1984 Jul; 54(1):5-12. PubMed ID: 6326999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Polychemoradiation treatment of non-small cell lung cancer].
    Linchenko IF; Danil'ian Vm
    Med Radiol (Mosk); 1985 Aug; 30(8):64-9. PubMed ID: 2993782
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials.
    Kawachi H; Fujimoto D; Morimoto T; Ito M; Teraoka S; Sato Y; Nagata K; Nakagawa A; Otsuka K; Tomii K
    Clin Lung Cancer; 2018 Sep; 19(5):e721-e734. PubMed ID: 29934133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study on prognostic factors in young and old lung cancer patients under chemo-radiotherapy].
    Chen TF; Jiang GL; Fu XL; Wang LJ; Qian H; Zhao S
    Zhonghua Zhong Liu Za Zhi; 2004 Nov; 26(11):692-6. PubMed ID: 15777511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiotherapy and integrated treatment in carcinoma of the lung].
    Bottero G; Novella V; Spinoglio G
    Minerva Med; 1988 Apr; 79(4):275-9. PubMed ID: 2835711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of thoracic irradiation plus combination chemotherapy for unresectable adenocarcinoma and large cell carcinoma of the lung.
    Eagan RT; Lee RE; Frytak S; Fleming TR; Cregan ET; Ingle JN; Kvols LK
    Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1401-5. PubMed ID: 231024
    [No Abstract]   [Full Text] [Related]  

  • 11. Radiotherapy plus razoxane for advanced limited extent carcinoma of the lung.
    Corder MP; Tewfik HH; Clamon GH; Platz CE; Leimert JT; Herbst KD; Byfield JE
    Cancer; 1984 May; 53(9):1852-6. PubMed ID: 6322961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung: preliminary report of a cooperative trial.
    Cox JD; Petrovich Z; Paig C; Stanley K
    Cancer; 1978 Sep; 42(3):1135-40. PubMed ID: 212171
    [No Abstract]   [Full Text] [Related]  

  • 13. [The immunomodulating role of indomethacin in the chemoradiation treatment of inoperable patients with lung cancer].
    Kas'ianenko IV; Pivniuk VM; Lisitsa AM; Kovalenko NA; Bagirian MA
    Vopr Onkol; 1992; 38(10):1183-7. PubMed ID: 1343143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical adjuvant therapy of non-small cell lung cancer.
    Holmes EC
    Chest; 1986 Apr; 89(4 Suppl):295S-300S. PubMed ID: 3007047
    [No Abstract]   [Full Text] [Related]  

  • 15. Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients?
    Al-Baimani K; Jonker H; Zhang T; Goss GD; Laurie SA; Nicholas G; Wheatley-Price P
    Curr Oncol; 2018 Aug; 25(4):e291-e297. PubMed ID: 30111974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
    Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
    Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
    Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC).
    van Harskamp G; Boven E; Vermorken JB; van Deutekom H; Stam J; Njo KH; Karim AB; Tierie AH; Golding RP; Pinedo HM
    Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1735-8. PubMed ID: 2822636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group.
    Cox JD; Samson MK; Herskovic AM; Abrams R; Koehler M
    Cancer Treat Rep; 1986 Oct; 70(10):1219-20. PubMed ID: 3019546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of multiple-fraction daily radiotherapy alternating with chemotherapy in patients with stage IV non-oat cell lung cancer.
    Arcangeli G; Righini R; Nervi C; Guerra A; Tirindelli D; Hopkins H; Looney W
    Cancer Treat Rep; 1985 Jan; 69(1):25-31. PubMed ID: 2981618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.